Literature DB >> 30463010

Computational Design of Epitope-Specific Functional Antibodies.

Guy Nimrod1, Sharon Fischman1, Mark Austin2, Asael Herman1, Feenagh Keyes2, Olga Leiderman1, David Hargreaves3, Marek Strajbl1, Jason Breed3, Shelley Klompus1, Kevin Minton2, Jennifer Spooner2, Andrew Buchanan2, Tristan J Vaughan2, Yanay Ofran4.   

Abstract

The ultimate goal of protein design is to introduce new biological activity. We propose a computational approach for designing functional antibodies by focusing on functional epitopes, integrating large-scale statistical analysis with multiple structural models. Machine learning is used to analyze these models and predict specific residue-residue contacts. We use this approach to design a functional antibody to counter the proinflammatory effect of the cytokine interleukin-17A (IL-17A). X-ray crystallography confirms that the designed antibody binds the targeted epitope and the interaction is mediated by the designed contacts. Cell-based assays confirm that the antibody is functional. Importantly, this approach does not rely on a high-quality 3D model of the designed complex or even a solved structure of the target. As demonstrated here, this approach can be used to design biologically active antibodies, removing some of the main hurdles in antibody design and in drug discovery.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-17A; antibody design; in silico protein design; protein modeling

Mesh:

Substances:

Year:  2018        PMID: 30463010     DOI: 10.1016/j.celrep.2018.10.081

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  12 in total

1.  De novo discovery of antibody drugs - great promise demands scrutiny.

Authors:  William J J Finlay; Alexey A Lugovskoy
Journal:  MAbs       Date:  2019-06-06       Impact factor: 5.857

Review 2.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

3.  Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide "Glycindel" Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson's Disease.

Authors:  Shawn C C Hsueh; Adekunle Aina; Andrei Yu Roman; Neil R Cashman; Xubiao Peng; Steven S Plotkin
Journal:  ACS Chem Neurosci       Date:  2022-07-15       Impact factor: 5.780

Review 4.  Computational design and experimental optimization of protein binders with prospects for biomedical applications.

Authors:  Alessandro Bonadio; Julia M Shifman
Journal:  Protein Eng Des Sel       Date:  2021-02-15       Impact factor: 1.952

5.  Higher Affinity Antibodies Bind With Lower Hydration and Flexibility in Large Scale Simulations.

Authors:  Mabel T Y Wong; Sebastian Kelm; Xiaofeng Liu; Richard D Taylor; Terry Baker; Jonathan W Essex
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

6.  Grafting Methionine on 1F1 Ab Increases the Broad-Activity on HA Structural-Conserved Residues of H1, H2, and H3 Influenza a Viruses.

Authors:  Hoa Thanh Le; Phuc-Chau Do; Ly Le
Journal:  Evol Bioinform Online       Date:  2021-03-16       Impact factor: 1.625

7.  Animal immunization merges with innovative technologies: A new paradigm shift in antibody discovery.

Authors:  Ponraj Prabakaran; Sambasiva P Rao; Maria Wendt
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 8.  Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.

Authors:  Bingying Liu; Daiwen Yang
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

9.  Increasing the Affinity of an O-Antigen Polysaccharide Binding Site in Shigella flexneri Bacteriophage Sf6 Tailspike Protein.

Authors:  Sonja Kunstmann; Olof Engström; Marko Wehle; Göran Widmalm; Mark Santer; Stefanie Barbirz
Journal:  Chemistry       Date:  2020-05-19       Impact factor: 5.236

10.  Computational approaches to therapeutic antibody design: established methods and emerging trends.

Authors:  Richard A Norman; Francesco Ambrosetti; Alexandre M J J Bonvin; Lucy J Colwell; Sebastian Kelm; Sandeep Kumar; Konrad Krawczyk
Journal:  Brief Bioinform       Date:  2020-09-25       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.